Literature DB >> 8189513

Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.

C Failla1, L Tomei, R De Francesco.   

Abstract

The proteolytic cleavages at the NS3-NS4A, NS4A-NS4B, NS4B-NS5A, and NS5A-NS5B junctions of hepatitis C virus (HCV) polyprotein are effected by the virus-encoded serine protease contained within NS3. Using transient expression in HeLa cells of cDNA fragments that code for regions of the HCV polyprotein, we studied whether viral functions other than NS3 are required for proteolytic processing at these sites. We found that, in addition to NS3, a C-terminal 33-amino-acid sequence of the NS4A protein is required for cleavage at the NS3-NS4A and NS4B-NS5A sites and that it accelerates the rate of cleavage at the NS5A-NS5B junction. In addition, we show that NS4A can activate the NS3 protease when supplied in trans. Our data suggest that HCV NS4A may be the functional analog of flavivirus NS2B and pestivirus p10 proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189513      PMCID: PMC236880     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.

Authors:  B Falgout; M Pethel; Y M Zhang; C J Lai
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 2.  Flavivirus genome organization, expression, and replication.

Authors:  T J Chambers; C S Hahn; R Galler; C M Rice
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

3.  Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site.

Authors:  C Lin; S M Amberg; T J Chambers; C M Rice
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

4.  Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.

Authors:  C F Arias; F Preugschat; J H Strauss
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

5.  Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity.

Authors:  B Falgout; R H Miller; C J Lai
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

8.  Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.

Authors:  A Grakoui; D W McCourt; C Wychowski; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor.

Authors:  M R Eckart; M Selby; F Masiarz; C Lee; K Berger; K Crawford; C Kuo; G Kuo; M Houghton; Q L Choo
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

10.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  117 in total

1.  Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.

Authors:  T Ueno; S Misawa; Y Ohba; M Matsumoto; M Mizunuma; N Kasai; K Tsumoto; I Kumagai; H Hayashi
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Conformational changes in the NS3 protease from hepatitis C virus strain Bk monitored by limited proteolysis and mass spectrometry.

Authors:  S Orrù; F Dal Piaz; A Casbarra; G Biasiol; R De Francesco; C Steinkühler; P Pucci
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

Review 3.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

Authors:  R Zhang; J Durkin; W T Windsor; C McNemar; L Ramanathan; H V Le
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 5.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 6.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 7.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3.

Authors:  V Schregel; S Jacobi; F Penin; N Tautz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

Review 9.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

10.  Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.

Authors:  S S Taremi; B Beyer; M Maher; N Yao; W Prosise; P C Weber; B A Malcolm
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.